Abstract:Introduction The incidence of anal squamous cell carcinoma (SCC) has been increasing over the last decades. Human papillomavirus (HPV) infection accounts for more than 90% of anal cancers, and HIV co‐infection increases the risk of invasive cancer. Men who have sex with men (MSM) with HIV are the highest risk group for developing anal high‐grade squamous intraepithelial lesions (aHSILs), which can be found in 45%–50% of these patients and are precursor lesions for invasive cancer. Anal cytology is an effective screening tool, but it lacks sensitivity. High‐resolution anoscopy (HRA) is the gold standard procedure for diagnosis and treatment of aHSILs. Recent data suggest that early detection and treatment of aHSILs could prevent the development of invasive cancer in this population. Objective The objective of the study was to describe the implementation of an office‐based screening program for anal cancer prevention in a Comprehensive Cancer Center in Brazil. Methods Training included participation in the International Anal Neoplasia Society (IANS) HRA course at UCSF Medical Center Mount Zion in San Francisco, CA, USA, by three colorectal cancer surgeons. In‐person and hands‐on training was provided by a specialist through the AIDS Malignancy Consortium (AMC) of the US NIH. Equipment purchased and provided by the AMC included a colposcope with a digital camera, a hands‐free mouse pedal, and a photo documentation imaging software program that allows images to be recorded for documentation and training purposes. Results The program was implemented in 2022 after a delay of more than two years due to the COVID‐19 pandemic. An average of 24 exams are performed monthly. Patients with HIV aged 35 years or older who are undergoing antiretroviral therapy were recruited from the metropolitan area of Rio de Janeiro and referred by primary care providers for screening. Patients diagnosed with aHSILs are scheduled for in‐office ablative treatment in the clinic. From March 2022 to June 2024, 324 exams were performed, and aHSIL was found in 38.2% of 220 high‐risk patients, including 45 of 129 MSMs (34.9%), 6 of 19 transgender women (31.6%), and 33 of 72 women living with HIV (45.8%). A total of 69 treatments for aHSIL were performed in 62 patients. Patients are followed on a regular basis and long‐term results are awaited, including the effectiveness of local therapy for aHSIL. Conclusions The screening and treatment program was successfully implemented in a tertiary comprehensive Cancer Center. Team training and external proctorship were decisive for the achievement of benchmark standards. The program aims to permanently provide screening for the prevention of anal cancer through the detection and treatment of aHSIL within the National Cancer Institute of Brazil for populations considered at‐risk for anal cancer.

International Anal Neoplasia Society's consensus guidelines for anal cancer screening

Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV

Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice

S345 Patient and Provider Perspective on Anal Cancer Screening in a Federally Qualified Health Center

Implementation of a Screening Program for High‐Grade Anal Dysplasia in High‐Risk Patients in a Tertiary Cancer Center

Five-year evaluation of Anal Cancer Screening Program in Men Who Have Sex With Men with HIV at Two Academic Center Clinics

Does use of anal cytology as a triage test improve the performance of high‐risk human papillomavirus screening in gay and bisexual men for anal cancer prevention?

Importance of anal cytology and screening for anal dysplasia in individuals living with HIV with an emphasis on women

Hotspots of Anal Cancer Screening in a High-risk Population: A Clinical Study on Free Provision, Best Method, Self-sampling, and Independent Risk Factors

Anal dysplasia and anal cancer screening practices among liver transplant centers in the United States: Results of an online survey

Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR)

Prevalence of Anal Human Papillomavirus Infection and Anal High-Grade Squamous Intraepithelial Lesions Among Men Who Have Sex With Men 50 Years and Older Living With or Without HIV

Psychological and utility-based quality of life impact of screening test results for anal precancerous lesions in gay and bisexual men: baseline findings from the Study of the Prevention of Anal Cancer

HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development

Prevalence of anal high‐risk human papillomavirus (HR‐HPV) types in people living with HIV and a history of cancer

Early detection of anal squamous cell carcinoma with the use of high resolution anoscopy

DNA high-risk HPV, mRNA HPV and P16 tests for diagnosis of anal cancer and precursor lesions: a systematic review and meta-analysis

Follow-Up to High-Resolution Anoscopy After Abnormal Anal Cytology in People Living with HIV

Self-collected versus clinician-collected anal swabs for anal cancer screening: A systematic review and meta-analysis

HPV Type Distribution in Benign, High-Grade Squamous Intraepithelial Lesions and Squamous Cell Cancers of the Anus by HIV Status

Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016